EconPapers    
Economics at your fingertips  
 

Cost of poor adherence to anti-hypertensive therapy in five European countries

F.S. Mennini, Andrea Marcellusi (), Johann Graf von der Schulenburg (), Alastair Gray (), Pierre Lévy, P. Sciattella, M. Soro, G. Staffiero, J. Zeidler, A. Maggioni and R. E. Schmieder
Additional contact information
Pierre Lévy: Legos - Laboratoire d'Economie et de Gestion des Organisations de Santé - Université Paris Dauphine-PSL - PSL - Université Paris sciences et lettres, LEDa - Laboratoire d'Economie de Dauphine - IRD - Institut de Recherche pour le Développement - Université Paris Dauphine-PSL - PSL - Université Paris sciences et lettres - CNRS - Centre National de la Recherche Scientifique

Post-Print from HAL

Abstract: The financial burden for EU health systems associated with cardiovascular disease (CV) has been estimated to be nearly €110 billion in 2006, corresponding to 10 % of total healthcare expenditure across EU or a mean €223 annual cost per capita. The main purpose of this study is to estimate the costs related to hypertension and the economic impact of increasing adherence to anti-hypertensive therapy in five European countries (Italy, Germany, France, Spain and England). A probabilistic prevalence-based decision tree model was developed to estimate the direct costs of CV related to hypertension (CV defined as: stroke, heart attack, heart failure) in five European countries. Our model considered adherence to hypertension treatment as a main driver of blood pressure (BP) control (BP

Keywords: Hypertension; Hypertensive therapy; Cost of illness; Adherence; Economic burden (search for similar items in EconPapers)
Date: 2015
Note: View the original document on HAL open archive server: https://hal.archives-ouvertes.fr/hal-01616348
References: Add references at CitEc
Citations: View citations in EconPapers (2) Track citations by RSS feed

Published in The European Journal of Health Economics, 2015, 16 (1), ⟨10.1007/s10198-013-0554-4⟩

There are no downloads for this item, see the EconPapers FAQ for hints about obtaining it.

Related works:
Journal Article: Cost of poor adherence to anti-hypertensive therapy in five European countries (2015) Downloads
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:hal:journl:hal-01616348

DOI: 10.1007/s10198-013-0554-4

Access Statistics for this paper

More papers in Post-Print from HAL
Bibliographic data for series maintained by CCSD ().

 
Page updated 2020-11-11
Handle: RePEc:hal:journl:hal-01616348